Get all your news in one place.
100's of premium titles.
One app.
Start reading
Radio France Internationale
Radio France Internationale
National
RFI

Biogaran sale talks renew fears over foreign control of French pharma

French pharmaceutical company Servier has announced at it has entered into exclusive negotiations with British-based European investment fund BC Partners to sell its generic drug subsidiary Biogaran, just over a year after an initial offer fell through. © AFP

France’s top generic drug maker, Biogaran, could soon be sold to a British investment fund, raising new fears about the country’s control over vital medicines.

French pharmaceutical group Servier has entered exclusive talks with BC Partners, a UK-based fund, to sell Biogaran. The deal has drawn attention from both the markets and political leaders.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.